Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   TANAFFOS   2016 , Volume 15 , Number 2; Page(s) 75 To 82.
 
Paper: 

COST ANALYSIS OF HOSPITALIZED PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A STATE-LEVEL CROSS-SECTIONAL STUDY

 
 
Author(s):  TORABIPOUR AMIN*, ASHRAFALSADAT HAKIM, AHMADI ANGALI KAMBIZ, DOLATSHAH MARZIEH, YUSOFZADEH MARYAM
 
* DEPARTMENT OF HEALTH SERVICES MANAGEMENT, SCHOOL OF HEALTH, AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES, AHVAZ, IRAN
 
Abstract: 

Background: Chronic obstructive pulmonary disease (COPD) is a common disease with important healthcare, social, and economic consequences. The aim of this study was to analyze the costs of hospitalizing patients with COPD.
Materials and Methods: In this state-level cross-sectional study, data from 165 COPD patients who had presented to our hospital between April 1, 2011 and March 31, 2013 were reviewed retrospectively. Patients were eligible for inclusion if they had a diagnosis of COPD [international classification of diseases-10 (ICD-10) code J44]. Costs of COPD patients were calculated by multiplying the amount of services used by the unit cost. Finally, we used multivariate regression analysis to determine predictors of hospital costs.
Results: Mean (SD) age of the patients was 68.6±12 years and 65.5% of them were?65. The mean (SD) and median length of stay (LOS) for patients were 8.5±11.5 and five days [IQR 3; 9], respectively. All hospital cost drivers had significant relationships with LOS, and the mean cost per patient was higher in patients with hospital LOS longer than nine days. Prolonged LOS (LOS>9 days) involved 830 bed/days. Therefore, the mean cost per each extra day of hospital stay was estimated to be US $115.80. The mean costs per patient with and without hypertension were US $1, 422.5 and US $627.4, respectively (P=0.017).
Conclusion: Hospitalization and medication costs were the two major cost drivers for patients hospitalized with COPD exacerbation. Duration of hospital stay, history of hypertension, and the number of clinical consultations other were significant predictors associated with hospital cost in patients with COPD.

 
Keyword(s): HOSPITAL COSTS, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, LENGTH OF STAY
 
 
References: 
  • Not Registered.
  •  
 
+ Click to Cite.
APA: Copy

TORABIPOUR, A., & ASHRAFALSADAT, H., & AHMADI ANGALI, K., & DOLATSHAH, M., & YUSOFZADEH, M. (2016). COST ANALYSIS OF HOSPITALIZED PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A STATE-LEVEL CROSS-SECTIONAL STUDY. TANAFFOS, 15(2), 75-82. https://www.sid.ir/en/journal/ViewPaper.aspx?id=569978



Vancouver: Copy

TORABIPOUR AMIN, ASHRAFALSADAT HAKIM, AHMADI ANGALI KAMBIZ, DOLATSHAH MARZIEH, YUSOFZADEH MARYAM. COST ANALYSIS OF HOSPITALIZED PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A STATE-LEVEL CROSS-SECTIONAL STUDY. TANAFFOS. 2016 [cited 2021May18];15(2):75-82. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=569978



IEEE: Copy

TORABIPOUR, A., ASHRAFALSADAT, H., AHMADI ANGALI, K., DOLATSHAH, M., YUSOFZADEH, M., 2016. COST ANALYSIS OF HOSPITALIZED PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A STATE-LEVEL CROSS-SECTIONAL STUDY. TANAFFOS, [online] 15(2), pp.75-82. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=569978.



 
  pdf-File
Yearly Visit 35
 
Latest on Blog
Enter SID Blog